Medical Xpress August 15, 2024
Robin Foster

The Biden administration said Thursday that it has signed deals with drug companies that will lower the prices on 10 of the most popular and expensive drugs used by American seniors.

Taxpayers should save $6 billion because of the new , while seniors using Medicare could save roughly $1.5 billion on their medications, the U.S. Centers for Medicare and Medicaid Services said in a news release announcing the new prices.

Those negotiated prices should lower the cost of drugs used by millions of older Americans to help manage diabetes, blood cancers and to prevent heart failure or .

The medications affected include the blood thinners Xarelto and Eliquis and the diabetes drugs Jardiance and Januvia. Medicare spent $50 billion...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Biotechnology, CMS, Congress / White House, Govt Agencies, HHS, Insurance, Medicare, Patient / Consumer, Pharma, Pharma / Biotech
Hospitals urge lawmakers to act as Medicare telehealth policies near expiration
Small practices, individual radiologists at a disadvantage in Medicare quality pay program
CMS Issues Final Rule on Returning Medicare and Medicaid Overpayments
Medicare Part D Spending on 10 Diabetes Drugs Hit $35.8B in 2023
Medicare Part D spending on weight loss drugs surges 364%: OIG

Share This Article